- How To Enter
Since its introduction a year ago, the GlycoWorks RapiFluor-MS N-Glycan Kit has saved biopharmaceutical laboratories approximately 3.9 years of work in just its first year of availability. This astounding number derives from the sale and adoption of this product into all 15 top-revenue-generating pharmaceutical companies and 90 percent of the top biopharmaceutical companies with glycoproteins in their pipeline. The kits help address what can become a bottleneck in the development and manufacturing of biopharmaceuticals, specifically the reporting of detailed information on N-glycosylation. This is accomplished with an innovative N-glycan labeling reagent that facilitates mass detection with substantial sensitivity gains versus current approaches.